Apollo Endosurgery lands $929K investment from Boston Partners

Devicemaker Apollo Endosurgery was worth over $15 million at the end of the most recent quarter, following several large investments in the company at the end of the third quarter of 2022, including $929,000 from Boston Partners, according to a Feb. 14 report from MarketBeat.

Advertisement

Boston Partners acquired a new position in shares, as did several other investors through the second and third quarters. Silverarc Capital Management boosted its shares by 5.7 percent, bringing its stock value to $6.26 million.

Lazard Asset Management boosted its shares by 77.5 percent, bringing its stock valuation to $39,000. Walleye Capital invested $44,000 and Jump Financial invested $62,000.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.